ECZEMA

This study tests whether the experimental medicine abrocitinib can safely improve moderate-to-severe eczema in children aged 6 to 12. About 150 children will be randomly assigned to receive either the drug or a placebo for 16 weeks. The goal is to see if the medicine clears the s…

This study is tracking 183 adults with moderate-to-severe eczema (atopic dermatitis) who take abrocitinib pills daily for up to 24 months. Researchers want to see how well the drug clears or nearly clears the skin in real-life conditions, not just in a lab. Participants can also …

This study tests whether a daily probiotic drink can improve immune function and reduce skin inflammation in women aged 40-60 going through menopause. Participants will drink either a probiotic or a plain milk drink for 8 weeks. Researchers will measure immune aging, inflammation…

This study tests an experimental drug called IMG-007 for adults with moderate-to-severe eczema (atopic dermatitis) that hasn't responded well to topical treatments. About 220 participants will receive either IMG-007 or a placebo to see if the drug safely reduces skin symptoms lik…

This study follows 200 people aged 12 and older with moderate-to-severe eczema who are starting a new prescription of abrocitinib. Researchers will track how well the drug controls symptoms like itching and rash over 12 months in real-world settings. The goal is to see if the imp…

This study is testing whether giving pregnant women extra fish oil (higher than usual doses) can lower the chance of their child developing asthma or persistent wheezing in the first three years of life. The researchers are enrolling 2,000 pregnant women in Denmark who have low b…

This study tests whether giving pregnant women higher doses of vitamin D than currently recommended can prevent asthma and persistent wheezing in their children during the first three years of life. Researchers will enroll 2,000 pregnant women in Denmark and follow their children…

This study is testing whether a moisturizing lotion can safely improve eczema symptoms in adults with mild-to-moderate atopic eczema. Fifteen participants will use the lotion for 4 weeks, with skin checks at the start and end. The goal is to see if the lotion reduces redness, dry…

This study tests if a spray made from ground cardamom seeds and a harmless skin bacteria (Roseomonas mucosa) can improve eczema symptoms in people aged 2 and older. Participants apply the spray 2-3 times a week for 14 weeks, and researchers track changes in rash severity and side…

This early-stage study tests a new drug called ARQ-234 for people with moderate to severe atopic dermatitis (eczema). The main goal is to check if the drug is safe and how the body processes it. The study includes healthy volunteers and people with eczema, who will receive either…

This study tests a new daily pill called soquelitinib for adults with moderate to severe eczema (atopic dermatitis). Researchers want to see if it reduces skin redness, itching, and rash better than a placebo. About 200 participants will take the pill or a dummy pill for 12 weeks…

This study tests a new cream called GX-03 in adults with moderate to severe eczema. About 100 participants will use either GX-03 or a plain moisturizer for 8 weeks. The goal is to see if GX-03 reduces itching and skin redness better than the moisturizer alone.

This study tests whether giving parents of C-section babies personalized gut health reports and advice can improve their infant's gut bacteria and reduce early signs of allergies like eczema. Researchers will compare three groups: one gets full guidance, another gets basic tips, …

This study looks at how treatments for eczema (atopic dermatitis) change the types and amounts of bacteria on the skin. Researchers will compare skin samples from people with eczema and healthy volunteers over one year. The goal is to understand how treatments affect the skin's m…

This study looks at the tiny organisms living on our skin—like bacteria and fungi—to see how they differ between healthy people and those with eczema (atopic dermatitis). Researchers will collect skin samples from 530 volunteers aged 2 to 50, including people with eczema and cert…

This study collects blood, urine, and skin samples from 200 adults with cutaneous T-cell lymphoma, eczema, or atopic dermatitis. The samples are stored and used for current and future research to better understand these skin conditions. Participants must be 18 or older and have a…